Total Raised

$172.44M

Investors Count

12

Deal Terms

2

Funding, Valuation & Revenue

12 Fundings

Conventus Orthopaedics has raised $172.44M over 12 rounds.

Conventus Orthopaedics's latest funding round was a Series D for $40.3M on May 18, 2020.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

5/18/2020

Series D

$40.3M

$XXM

0

FY undefined

1

5/14/2020

Series C

$24.46M

$XXM

0

FY undefined

1

1/10/2019

Convertible Note

$5M

Undisclosed Investors

$XXM

0

FY undefined

1

1/2/2018

Loan

$XXM

$XXM

0

FY undefined

10

5/9/2017

Series B

$XXM

$XXM

0

FY undefined

10

Date

5/18/2020

5/14/2020

1/10/2019

1/2/2018

5/9/2017

Round

Series D

Series C

Convertible Note

Loan

Series B

Amount

$40.3M

$24.46M

$5M

$XXM

$XXM

Investors

Undisclosed Investors

Valuation

$XXM

$XXM

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

1

1

10

10

Start free trial
New call-to-action

Conventus Orthopaedics Deal Terms

2 Deal Terms

Conventus Orthopaedics's deal structure is available for 2 funding rounds, including their Series A - III from October 29, 2015.

Round

Series A - III

Series A

Funding Date

$XXM

$XXM

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$XXM

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

$XXM

Board Voting

$XXM

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series A - III

$XXM

$XXM

$XXM

$XXM

Series A

$XXM

$XXM

$XXM

$XXM

Conventus Orthopaedics Investors

12 Investors

Conventus Orthopaedics has 12 investors. Deerfield invested in Conventus Orthopaedics's Series D funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

12/2/2014

5/18/2020

5
Series A - II, Series A - III (2015), Series B (2017), Series C (2020), Series D (2020)

Venture Capital

New York

1/2/2018

1/2/2018

Horizon Technology Finance
1
Loan

Debt & Specialty Finance

Connecticut

6/19/2009

10/29/2015

5
Series A, Debt - II (2013), Debt - III (2013), Series A - II (2014), Series A - III (2015)

Venture Capital

Massachusetts

00/00/0000

00/00/0000

SightLine Partners

Subscribe to see more

Venture Capital

Minnesota

00/00/0000

00/00/0000

BioStar Capital

Subscribe to see more

Venture Capital

Michigan

First funding

12/2/2014

1/2/2018

6/19/2009

00/00/0000

00/00/0000

Last Funding

5/18/2020

1/2/2018

10/29/2015

00/00/0000

00/00/0000

Investor

Horizon Technology Finance

SightLine Partners

BioStar Capital

Rounds

5
Series A - II, Series A - III (2015), Series B (2017), Series C (2020), Series D (2020)
1
Loan
5
Series A, Debt - II (2013), Debt - III (2013), Series A - II (2014), Series A - III (2015)

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Debt & Specialty Finance

Venture Capital

Venture Capital

Venture Capital

Location

New York

Connecticut

Massachusetts

Minnesota

Michigan

Conventus Orthopaedics Acquisitions

2 Acquisitions

Conventus Orthopaedics acquired 2 companies. Their latest acquisition was Flower Orthopedics on April 30, 2020.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

4/30/2020

Other

$XXM

$9.35M

Acquired

1

12/19/2019

Subscribe to see more

$XXM

Subscribe to see more

10

Date

4/30/2020

12/19/2019

Investment Stage

Other

Companies

Subscribe to see more

Valuation

$XXM

$XXM

Total Funding

$9.35M

Note

Acquired

Subscribe to see more

Sources

1

10

New call-to-action

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.